Selecta Biosciences, Inc. Co-Founder Named 2009 Mass High Tech All Star
WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences, Inc., a biopharmaceutical company focused on discovering and developing the first generation of nanoparticle-based vaccines and immunomodulatory drugs for the treatment and prevention of human diseases, announced today that Omid Farokhzad, M.D., co-founder and Vice Chair, has been named as a 2009 Mass High Tech All Star for his contributions to the life sciences industry. Now in its fourteenth year, the annual All Star awards program recognizes dynamic and influential leaders across several business and technology sectors in New England’s innovation economy. This year’s honorees are profiled in a special supplement of Mass High Tech: The Journal of New England Technology.